Corning® MSCulture Max™ Media is an advanced cell culture solution designed to maximize human mesenchymal stem cell (hMSC) expansion while simplifying workflow. The media eliminates the need for media exchanges and surface coating, enabling consistent, high-yield performance across research and manufacturing environments. Available in three formulations — standard research-grade, xeno-free, and GMP-grade — Corning MSCulture Max provides a seamless transition from discovery to clinical application and works in conjunction with Corning’s stacked vessel portfolio as you scale-up or scale-out.
Features and benefits
Corning MSCulture Max Media delivers high-performance expansion in batch culture systems, achieving over tenfold hMSC expansion within four to five days without requiring media changes. This not only boosts productivity but also reduces time, labor and material costs. Its transition-friendly design supports users through every stage of the development process, from early research through clinical-scale production. With no media exchanges or surface coatings required, MSCulture Max ensures efficient and scalable bioprocessing while minimizing in-process risk and variability.
Applications
Corning MSCulture Max Media supports a broad range of stem cell-based research and therapeutic applications. In regenerative medicine and cell therapy manufacturing, it enables robust MSC expansion for use in developing treatments for osteoarthritis, cardiovascular disease, and autoimmune disorders.
The media also supports tissue engineering applications where MSCs are used to engineer bone, cartilage and vascular tissue constructs, promoting effective functional recovery. Additionally, it serves as a powerful platform for drug discovery and disease modeling, allowing researchers to assess drug efficacy and toxicity or replicate disease states in vitro with reliable results.